ukrr annual informatics meeting, september 2013 highlights from the 15 th annual report rishi pruthi...
TRANSCRIPT
UKRR Annual Informatics Meeting, September 2013
Highlights from the 15th Annual Report
Rishi Pruthi
Research Fellow
UK Renal Registry
The Fifth Edition of the Clinical Practice Guidelines
http://www.renal.org/Clinical/GuidelinesSection/Guidelines.aspx
Module
Blood-borne viruses Haemodialysis
Vascular Access For Haemodialysis Peritoneal dialysisPeritoneal access Planning, initiation & withdrawal of RRT Assessment of the Potential Kidney Transplant Recipient Acute Kidney Injury Nutrition in CKD Anaemia in CKD Cardiovascular disease in CKD CKD-Mineral and Bone Disorders (CKD-MBD) Detection, Monitoring and Care of Patients with CKD Post-operative Care of the Kidney Transplant Recipient RA and ART Guideline on Water Treatment Facilities, Dialysis Water and Dialysis Fluid Quality for Haemodialysis and Related Therapies
RRT incidence rates between 1980 and 2011
DEMOGRAPHY
UK Renal Registry 15th Annual Report
UK Renal Registry 15th Annual Report
Figure 1.6. Median age of incident RRT patients by centre in 2011White points indicate transplant centres
Population aged 65 and over, 2011England and Wales local and unitary authorities
UK Renal Registry 15th Annual Report
Figure 1.2. Age/gender standardised incidence ratio(2006–2011) by percentage non-White
RRT incidence rates in the countriesof the UK 1990–2011
UK Renal Registry 15th Annual Report
UK Renal Registry 15th Annual Report
Figure 1.14. International comparison of RRT incidence rates in 2010Non UK data from USRDS
Prevalence rate of RRT patients per million populationby age and gender on 31/12/2010
Growth in prevalent patients by treatmentmodality at the end of each year 1997–2011
UK Renal Registry 15th Annual Report
MODALITY
UK Renal Registry 15th Annual Report
RRT modality at 90 days(incident cohort 1/10/2010 to 30/09/2011)
UK Renal Registry 15th Annual Report
Figure 2.6. Treatment modality in prevalent RRT patients on31/12/2011
UK Renal Registry 15th Annual Report
Figure 2.7. Treatment modality distribution by age in prevalentRRT patients on 31/12/2011
UK Renal Registry 15th Annual Report
Figure 9.4. Median time to wait listing for a kidney transplant,by renal centre (centres with <10 patients excluded)
ACCESS TO TRANSPANTATION
• Patients starting dialysis in a non-transplanting centre was associated with being less likely to be registered for transplantation (adjusted OR 0.8, 0.74-87)
• After adjustment for age, ethnicity, gender an PRD there were significant centre differences for the probability of being activated on the kidney tx waiting list and the probability of receiving a renal transplant (all sources)
ACCESS TO TRANSPANTATION
UK Renal Registry 15th Annual Report
Figure 4.3. Primary renal disease percentage in incident and prevalent paediatricERF patients in 2011 for whom a causative diagnosis was reported
UK Renal Registry 15th Annual Report
Figure 4.4. Treatment modality at start of RRT by 5 year time period
OPPORTUNITIES & THE FUTURE
• CKD stage 5 patients to understand conservative and withdrawal issues to allow adjustment for survival and other outcomes (quality of life)
• AKI• RADAR• Improving data returns and New Renal Dataset• Specific need for research focused on improving
outcomes in the elderly multi-morbid population
20
VALID REPRODUCIBLE
RELIABLE COMPLETE
